News & Events
Have a question or just need help?
Contact us for Service and Support
BioChain Launches CancerSeq™ Genetically Characterized Paraffin Tissue Tumor Blocks
Newark, CA (March 11, 2013)BioChain Launches CancerSeq™ Genetically Characterized Paraffin Tissue Tumor Blocks.
BioChain licenses Septin9 test for colorectal cancer from Epigenomics
Newark, CA (March 7, 2013)BioChain licenses Septin9 test for colorectal cancer from EpigenomicsBioChain Receives Regulatory Approval of Chlamydia trachomatis PCR Test in China
Beijing, China (January 15, 2013)BioChain Receives Regulatory Approval of Chlamydia trachomatis PCR Test in ChinaBioChain Receives Regulatory Approval of Ureaplasma urealyticum PCR Test in China
Beijing, China (January 15, 2013)BioChain Receives Regulatory Approval of Ureaplasma urealyticum PCR Test in ChinaBioChain Receives Regulatory Approval of Neisseria Gonorrhoeae PCR Test in China
Beijing, China (January 15, 2013)BioChain Receives Regulatory Approval of Neisseria Gonorrhoeae PCR Test in ChinaBioChain Will Attend ASHG
San Francisco, CA (September 28, 2012)BioChain Will Attend ASHGBioChain Receives Regulatory Approval of Human Cytomegalovirus PCR Test in China
Beijing China (September 10, 2012)BioChain Receives Regulatory Approval of Human Cytomegalovirus PCR Test in ChinaBioChain Receives Regulatory Approval of Herpes Simplex Virus PCR Test in China
Beijing China (September 10, 2012)BioChain Receives Regulatory Approval of Herpes Simplex Virus PCR Test in ChinaBioChain Establishes Reproductive Health Focused Reference Laboratory in Beijing, China
Beijing, China (August 10, 2012)BioChain Establishes Reproductive Health Focused Reference Laboratory in Beijing, ChinaBioChain Attended AACC Conference to Seek Licensing of Its Homogeneous Assay Technology for Clinical Diagnostics
Los Angeles, CA (July 17, 2012)BioChain Attended AACC Conference to Seek Licensing of Its Homogeneous Assay Technology for Clinical Diagnostics
Pre[1]
[2]
[3]
Next